puerperal bleeding. complications of the the puerperium unspecified
Conditions
Interventions
Intervention 1: Group A:every 12 hour,250 mg oral transexamic acid capsule with two ferrous sulfate is given. Intervention 2: Group B: every 12 hour 1 tablet 5 mg medroxyprogestrone with two ferrous
Treatment - Drugs
Group A:every 12 hour,250 mg oral transexamic acid capsule with two ferrous sulfate is given.
Group B: every 12 hour 1 tablet 5 mg medroxyprogestrone with two ferrous sulfat is given
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criterias: women 15-45 ages with prolonged puerperal bleeding; dizziness; hypotension; skin allergy because of tampone use;and 30 days after delivery. Exclusion critreias: Birth canal lacerations; retained placenta; myoma and endometrial polyps; history of chronic diseases such as: hepatic, renal,diabetes, thromboembolic and coagulative disorders; anticoagulative drug use ; and thrombocytopenia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Headache and dizziness. Timepoint: Before and six weeks after intervention. Method of measurement: Patient report.;Spotting. Timepoint: Before and six weeks after intervention. Method of measurement: Patient report.;Repeat intervention. Timepoint: Up to six weeks after intervention. Method of measurement: Surgery,D&C,administration of drug. | — |
Primary
| Measure | Time frame |
|---|---|
| The volume of bleeding. Timepoint: Before and six weeks after intervention. Method of measurement: The number of used pads before and after intervention.;Hb level. Timepoint: Before and six weeks after intervention. Method of measurement: Hb level measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactfiroozeh veisi
Kermanshah University of Medical Sciences
Outcome results
None listed